{ 156件 }
Aso K, Kono M, Kanda M, Kudo Y, Sakiyama K, Hisada R, Karino K, Ueda Y, Nakazawa D, Fujieda Y, Kato M, Amengual O and Atsumi T.
Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming.
Nature Commun. in press.
令和4年度 北海道大学大学院医学研究院 優秀論文賞 阿部 靖矢先生
令和4年度 北海道大学大学院医学研究院 優秀論文賞 狩野 皓平先生
Karino K, Kono M, Kanda M, Atsumi T.
Reply.
Arthritis Rheumatol. in press.
IF=15.483
Kato M, Ninagawa K, Atsumi T.
Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: Reply.
Rheumatology (Oxford). in press
IF=7.046
Aso K, Fujieda Y, Atsumi T.
Homonymous hemianopsia and headache with mass-like lesion Annals of the Rheumatic Diseases.
IF 19.103
Scherlinger M, Pan W, Hisada R, Boulougoura A, Yoshida N, Vukelic M, Umeda M, Krishfield S, Tsokos MG, Tsokos GC.
Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity.
Sci Adv. 2022;8(48):eadc9657.
IF = 14.980
Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada K, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, Takeuchi T, Murakawa Y, Sugihara T, Saito M, Hayashi T, Furuta S, Tamura N, Karasawa K, Banno S, Endo S, Majima M, Kaname S, Arimura Y, Harigai M.
Nation-wide Cohort Study of Remission Induction Therapy using Rituximab in Japanese patients with ANCA-Associated Vasculitis:
effectiveness and safety in the first six months.
Modern Rheumatology. in press.
IF: 2.862
Abe N, Kono Michihiro, Kono Michihito*, Katsuyama T, Ohmura K, Sato T, Karino K, Fujieda Y, Kato M, Hasebe R, Murakami M, and Atsumi T.
Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel
vasculitis: a preliminary observational study. Frontiers in Immunology in press
IF=8.786
第32回日本リウマチ学会北海道・東北支部学術集会 若手リウマチ医奨励賞受賞者セッション 優秀賞 鎌田 和郎先生